The use of programme budgeting and marginal analysis (PBMA) in the UK has grown since the National Health Service (NHS) reforms of 1991. It is a pragmatic form of economic evaluation and has been promoted to help aid the purchasing decisions of health authorities and boards and, to a lesser extent, general practitioner (GP) fundholders.lv Although the new Labour government is committed to ending the internal market, this does not in any way diminish the need for PBMA. With limited resources, there will always be a need to set priorities and make decisions about how best to provide health services. So, although the policy context may have changed, the potential for PBMA to be used has not.
Yet there are still doubts about the usefulness of PBMA. How critics define 'usefulness' is often unclear. However, these doubts are related principally to the assumptions it uses and to the lack of any published reports of PBMA exercises being followed-up to examine whether they had any impact.
One source of these doubts is the calculation of 'savings' in marginal analyses. This often assumes that resources can be released. In practice, many costs are fixed and resource use is lumpy and indivisible; some resources cannot be divided up into smaller parts. In the short to medium term, a shift of service provision can only release those resources that can be pragmatically released. More often than not, this means that fewer resources can be released than has been estimated in the marginal analysis. Given that capacity cannot always be reduced, total costs of any shift may in fact increase in the short to medium term, since services may run in parallel. Although this is a well-known phenomenon and is not specific to PBMA, it is still something that must be recognized more explicitly by protagonists.
There are also transaction costs in trying to shift resources. The costs of persuading GPs to alter referral behaviour or hospital doctors to change their practice, in terms of time, plus the organizational costs involved if a shift is to occur, need to be quantified and weighed up against the (variable) cost savings estimated in the marginal analysis. Such costs can be viewed as barriers to change. There are also other barriers to implementing results, such as a changing local political climate and not being in tune with the purchasers' decision-making cycle." Conducting the exercise itself also uses scarce resources, since a group of health care professionals is usually required to meet throughout, while the relevant information is gathered from within the organization. If these costs outweigh the potential savings, then it would be inappropriate to try to shift resources, unless it was certain that benefits to patients would be forthcoming, and that these were worth the extra cost. Again, this issue is not specific to PBMA, although it may be the case that PBMA makes these issues more explicit.
An example of these issues is provided by a recent PBMA of general surgery services undertaken by a purchaser in Scotland -the Argyll and Clyde Health Board." A professional advisory group and a team led by a public health specialist scrutinized the range of procedures forming the specialty of general surgery. Current expenditure and activity (the programme budget) on some procedures was estimated. The main margin that they were examining was changing the purchasing of surgical services from three hospitals in a neighbouring Health Board to hospitals within the boundaries of their own Health Board. The changes in costs and benefits were then examined using existing data.
Costs were based on contract prices and prepared by the contract accountant. For the proposed expansion in activity in the two local hospitals, full costs were reduced to marginal (i.e. taking account of only those resources that could realistically be released) because these two providers were willing to contract for increases in activity on such a basis. One of these hospital's marginal costs were all estimated at 80% of full cost, except for vascular surgery which was at full cost. The other hospital's marginal costs were estimated at 20%. Reductions in activity were valued at full cost at the relevant hospitals in the neighbouring district. The assumptions about the costs were based on practical experience of the contract accountant in negotiating with the individual hospitals when shifting services.
Only when the results are implemented can these assumptions be tested in the negotiation process. In this respect, PBMA provided the purchaser with locally. generated information that it can use as a basis for negotiation and implementing change.
It was assumed that the effectiveness of clinical care would be the same in the local hospitals and that better access to services might be beneficial to patients. The results showed that although the margins identified potential cost savings, these were small (between £2000 and £45000 per year, depending on the procedure(s) and hospitals involved). It was judged by the purchaser that the potential transaction costs of achieving change could outweigh these savings. It was therefore decided that it was not feasible to change the location of services. As well as the costs of setting up new services, potential transaction costs included the time costs of negotiating changes in contracts and the effort involved in trying to change GPs' established referral behaviour. Furthermore, shifting services between hospitals ignores the J Health Serv Res Policy Volume4 Number 1January 1999 1 cost advantages of economies of scope. This is where the cost of providing certain services is dependent on the existence of other services in a hospital.
Although the PBMA exercise did not lead to any changes in services, the purchaser found it a useful framework on which to initiate discussion about changes with providers in a transparent way. The purchaser felt that PBMA formed an essential framework for testing strategic decisions. One of the main hypotheses of the purchaser's acute strategy -that stopping general surgical referrals to hospitals in the neighbouring district and re-purchasing from local hospitals might release resources -was shown to be inaccurate and the strategy was consequently revised. So, although the PBMA had no effect on the decisions made, it did have an effect on policy. This distinction is important.
Many of the criticisms of PBMA, in terms of it 'working', can also be made against economic evaluation more generally, and, to a lesser extent, randomized trials. Implementing the findings of research is still one of the major concerns in the debate about the usefulness of 'evidence-based medicine' and the development of guidelines. PBMA is not alone. PBMA may in fact have a distinct advantage in terms of being locally relevant. It does not pretend to be generalizable. Unlike economic evaluations conducted by academic researchers, the stakeholders who will be involved in implementing the results are usually involved in the exercise from the beginning. Information comes from the purchasers and the relevant health care professionals. Because of this, PBMA has more of a chance of being linked with the purchasers' decision-making cycles compared with evaluations conducted solely by academics.
For PBMA to have an impact it does not necessarily have to result in change taking place. There may be Primary care and the US health care system good reasons why change cannot take place, as was seen in Argyll and Clyde. Its value has always been in the framework it uses and the way of thinking that this framework represents. The process of the exercise is often as important as the outcome. However, there is still some effort to be made in following up PBMA exercises after they have been completed and sharing with others the issues that arise so that lessons can be learned. It is as much a mistake for policy-makers to expect that PBMA will give them the 'right' answer, as it is for researchers to assume that PBMA results can be implemented easily.
Primary care and the US health care system
In many Western European countries the phrase 'general practice' has been replaced by 'primary care', to indicate that first-contact health care is provided by professionals other than doctors, such as nurses, community pharmacists and optometrists. The same change has taken place in many university departments of general practice/primary care, to reflect the critical contributions made to teaching and research by nonclinical academics, including sociologists, epidemiologists, economists and psychologists. Primary care has become almost self-consciously politically correct.
Conversely, and potentially damagingly, a different perception of primary care, accompanied by an overmedicalized view of health and illness, persists in the specialist-dominated health care systems of the USA. Oxymoronic phrases such as 'primary care cardiologist', a pejorative use of the term 'gatekeeper' and a payment system attuned more to intervention than prevention conspire to hold American health care in an economic straitjacket, A change of course is required, which demands a re-definition of primary care, the implementation of which will require the energetic support of health care policy-makers, medical educators and the medical profession.
The Alma Ata declaration of 1976 generated a definition of primary care that was broad enough to include almost everyone whilst being cautious enough to offend no one.' Primary care is first-contact health care, in which continuity, comprehensiveness and coordination are key components and to which access is as free as the ambient health care system will allow. More recently, a committee of the Institute of Medicine in the USA
